{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:09:43Z","timestamp":1782407383267,"version":"3.54.5"},"reference-count":120,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01854","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:55:51Z","timestamp":1565052951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Adoptive T Cell Therapy Following Haploidentical Hematopoietic Stem Cell Transplantation"],"prefix":"10.3389","volume":"10","author":[{"given":"Ping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siok-Keen","family":"Tey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.bbmt.2017.05.035","article-title":"Current use and trends in hematopoietic cell transplantation in the United States","volume":"23","author":"D'Souza","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/bmt.2017.34","article-title":"Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report","volume":"52","author":"Passweg","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after alphabeta T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.2014.60.4777","article-title":"Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults","volume":"33","author":"Kasamon","year":"2015","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","article-title":"Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1158\/1078-0432.CCR-15-2335","article-title":"Haploidentical vs. matched-sibling transplant in adults with philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III randomized study","volume":"22","author":"Wang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","article-title":"Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant","volume":"10","author":"Xu","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/leu.2016.110","article-title":"Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant","volume":"30","author":"Wang","year":"2016","journal-title":"Leukemia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","article-title":"Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide","volume":"8","author":"O'Donnell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nrclinonc.2015.234","article-title":"Modern approaches to HLA-haploidentical blood or marrow transplantation","volume":"13","author":"Kanakry","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.bbmt.2013.11.028","article-title":"Immune reconstitution after haploidentical hematopoietic stem cell transplantation","volume":"20","author":"Chang","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e86252","DOI":"10.1172\/jci.insight.86252","article-title":"Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide","volume":"1","author":"Kanakry","year":"2016","journal-title":"JCI Insight"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1172\/JCI90595","article-title":"Alloimmune T cells in transplantation","volume":"127","author":"DeWolf","year":"2017","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","article-title":"Inducible apoptosis as a safety switch for adoptive cell therapy","volume":"365","author":"Di Stasi","year":"2011","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1182\/blood-2008-03-143636","article-title":"Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies","volume":"112","author":"Davies","year":"2008","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/MOH.0b013e328353bc7d","article-title":"Immune reconstitution after hematopoietic cell transplantation","volume":"19","author":"Bosch","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.smim.2007.10.004","article-title":"T cell immune reconstitution following lymphodepletion","volume":"19","author":"Williams","year":"2007","journal-title":"Semin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1182\/blood-2014-07-589176","article-title":"The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation","volume":"124","author":"Politikos","year":"2014","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1182\/blood-2015-03-631853","article-title":"CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRbeta repertoire","volume":"125","author":"Suessmuth","year":"2015","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/leu.2016.321","article-title":"Tracking T-cell immune reconstitution after TCRalphabeta\/CD19-depleted hematopoietic cells transplantation in children","volume":"31","author":"Zvyagin","year":"2017","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nm.3100","article-title":"Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation","volume":"19","author":"van Heijst","year":"2013","journal-title":"Nat Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.1182\/blood-2011-02-334623","article-title":"Thymic T-cell development in allogeneic stem cell transplantation","volume":"117","author":"Krenger","year":"2011","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1182\/blood.V96.6.2299","article-title":"Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity","volume":"96","author":"Roux","year":"2000","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1182\/blood-2008-09-176594","article-title":"Acute graft-vs.-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation","volume":"113","author":"Clave","year":"2009","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nri2187","article-title":"Generating intrathymic microenvironments to establish T-cell tolerance","volume":"7","author":"Anderson","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nri3667","article-title":"Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see)","volume":"14","author":"Klein","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1182\/blood-2003-01-0266","article-title":"Impaired thymic negative selection causes autoimmune graft-vs.-host disease","volume":"102","author":"Teshima","year":"2003","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.4049\/jimmunol.1300657","article-title":"Thymic damage, impaired negative selection, and development of chronic graft-vs.-host disease caused by donor CD4+ and CD8+ T cells","volume":"191","author":"Wu","year":"2013","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1182\/blood-2015-10-672345","article-title":"Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD","volume":"127","author":"Alho","year":"2016","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2007.06510.x","article-title":"Advances in the understanding of acute graft-vs.-host disease","volume":"137","author":"Morris","year":"2007","journal-title":"Br J Haematol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1182\/blood-2011-03-340315","article-title":"Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORgammat in mice","volume":"118","author":"Yu","year":"2011","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell-depleted haploidentical \u201cthree-loci\u201d incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cell.2007.01.048","article-title":"How a single T cell receptor recognizes both self and foreign MHC","volume":"129","author":"Colf","year":"2007","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"34324","DOI":"10.1074\/jbc.M606755200","article-title":"Alloreactivity between disparate cognate and allogeneic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry","volume":"281","author":"Archbold","year":"2006","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1084\/jem.179.4.1155","article-title":"An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-vs.-host disease","volume":"179","author":"Burrows","year":"1994","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells vs. bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1182\/blood-2002-04-1200","article-title":"G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases","volume":"102","author":"Franzke","year":"2003","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1182\/blood-2001-12-0291","article-title":"Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells","volume":"100","author":"Rutella","year":"2002","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood.V95.8.2484.008k01_2484_2490","article-title":"Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells","volume":"95","author":"Arpinati","year":"2000","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1182\/blood-2009-11-256495","article-title":"Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma","volume":"116","author":"Hill","year":"2010","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1182\/blood-2015-01-622662","article-title":"Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects","volume":"126","author":"Gartlan","year":"2015","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.bmt.1703779","article-title":"Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study","volume":"31","author":"Lewalle","year":"2003","journal-title":"Bone Marrow Transpl"},{"key":"B47","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3324\/haematol.10570","article-title":"Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched\/haploidentical T-cell-replete hematopoietic stem cell transplantation","volume":"92","author":"Huang","year":"2007","journal-title":"Haematologica"},{"key":"B48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00277-018-3482-7","article-title":"Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies","volume":"98","author":"Gao","year":"2019","journal-title":"Ann Hematol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ajh.24949","article-title":"Donor lymphocyte infusion and methotrexate for immune recovery after T-cell depleted haploidentical transplantation","volume":"93","author":"Gilman","year":"2018","journal-title":"Am J Hematol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/infdis\/jix357","article-title":"Cytomegalovirus-specific T-cell transfer for refractory cytomegalovirus infection after haploidentical stem cell transplantation: the quantitative and qualitative immune recovery for cytomegalovirus","volume":"216","author":"Pei","year":"2017","journal-title":"J Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, epstein-barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1200\/JCO.2011.39.8495","article-title":"Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation","volume":"31","author":"Icheva","year":"2013","journal-title":"J Clin Oncol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","article-title":"T cells for viral infections after allogeneic hematopoietic stem cell transplant","volume":"127","author":"Bollard","year":"2016","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/bmt.2017.232","article-title":"Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT","volume":"53","author":"Qian","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbmt.2017.10.004","article-title":"Virus-specific T cells: broadening applicability","volume":"24","author":"Barrett","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B60","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.beha.2011.06.001","article-title":"Novel strategies for adoptive therapy following HLA disparate transplants","volume":"24","author":"O'Reilly","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"B61","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood.V95.1.286","article-title":"HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide","volume":"95","author":"Ohminami","year":"2000","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1182\/blood-2005-01-0146","article-title":"Elimination of human leukemia cells in NOD\/SCID mice by WT1-TCR gene-transduced human T cells","volume":"106","author":"Xue","year":"2005","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.1158\/1078-0432.CCR-04-1040","article-title":"In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity","volume":"10","author":"Doubrovina","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B64","first-page":"2675","article-title":"A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia","volume":"59","author":"Molldrem","year":"1999","journal-title":"Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1182\/blood.V98.10.2887","article-title":"Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein","volume":"98","author":"Clark","year":"2001","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1182\/blood-2010-08-300376","article-title":"High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells","volume":"117","author":"Quintarelli","year":"2011","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.1182\/blood-2010-09-308569","article-title":"Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia","volume":"117","author":"Bornhauser","year":"2011","journal-title":"Blood"},{"key":"B68","doi-asserted-by":"publisher","first-page":"174ra27","DOI":"10.1126\/scitranslmed.3004916","article-title":"Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients","volume":"5","author":"Chapuis","year":"2013","journal-title":"Sci Transl Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/leu.2013.66","article-title":"Generation of multi-leukemia antigen-specific T cells to enhance the graft-vs.-leukemia effect after allogeneic stem cell transplant","volume":"27","author":"Weber","year":"2013","journal-title":"Leukemia"},{"key":"B70","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1182\/blood-2016-09-737700","article-title":"Genome-wide minor histocompatibility matching as related to the risk of graft-vs.-host disease","volume":"129","author":"Martin","year":"2017","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bbmt.2005.09.017","article-title":"Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: a survey of different populations","volume":"12","author":"Di Terlizzi","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"B72","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1182\/blood-2017-07-791608","article-title":"Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse","volume":"131","author":"Dossa","year":"2018","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0140-6736(02)09413-8","article-title":"Immune reconstitution without graft-vs.-host disease after haemopoietic stem-cell transplantation: a phase 1\/2 study","volume":"360","author":"Andre-Schmutz","year":"2002","journal-title":"Lancet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.bbmt.2005.11.051","article-title":"Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation","volume":"108","author":"Amrolia","year":"2006","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15970","article-title":"Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-vs.-host disease (GVHD) in the absence of GVHD prophylaxis","author":"Roy","year":"2019","journal-title":"Br J Haematol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jcyt.2018.02.016","article-title":"Phase II study of haploidentical stem cell transplantation using ex vivo photodepletion of donor lymphocyte infusions to eliminate anti-host reactivity results in low relapse rates and high survival rates: final 2 year follow-up","volume":"20","author":"Roy","year":"2018","journal-title":"Cytotherapy"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJM199906033402202","article-title":"Transplantation of anergic histoincompatible bone marrow allografts","volume":"340","author":"Guinan","year":"1999","journal-title":"N Engl J Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1158\/1078-0432.CCR-18-0449","article-title":"Infusion of alloanergized donor lymphocytes after CD34-selected haploidentical myeloablative hematopoietic stem cell transplantation","volume":"24","author":"Davies","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fimmu.2014.00016","article-title":"Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells","volume":"5","author":"Bacchetta","year":"2014","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1182\/blood.V87.11.4887.bloodjournal87114887","article-title":"Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-vs.-host disease and extend the donor pool","volume":"87","author":"Gribben","year":"1996","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1182\/blood-2005-01-0393","article-title":"Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-vs.-host disease in older patients undergoing matched sibling donor stem cell transplantation","volume":"106","author":"Solomon","year":"2005","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T cells do not induce graft-vs.-host disease","volume":"112","author":"Anderson","year":"2003","journal-title":"J Clin Invest"},{"key":"B84","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.bbmt.2014.01.032","article-title":"Engineering human peripheral blood stem cell grafts that are depleted of naive T cells and retain functional pathogen-specific memory T cells","volume":"20","author":"Bleakley","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1172\/JCI81229","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/bmt.2015.139","article-title":"Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies","volume":"50","author":"Triplett","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B87","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41409-017-0035-y","article-title":"Low-dose donor memory T-cell infusion after TCR alpha\/beta depleted unrelated and haploidentical transplantation: results of a pilot trial","volume":"53","author":"Maschan","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1182\/blood-2005-06-2529","article-title":"Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD","volume":"107","author":"Rieger","year":"2006","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","article-title":"Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-vs.-host disease","volume":"106","author":"Zorn","year":"2005","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","first-page":"83ra41","DOI":"10.1126\/scitranslmed.3001809","article-title":"Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity","volume":"3","author":"Hippen","year":"2011","journal-title":"Sci Transl Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exphem.2016.09.008","article-title":"Clinical-grade regulatory T cells: comparative analysis of large-scale expansion conditions","volume":"45","author":"Velaga","year":"2017","journal-title":"Exp Hematol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.4049\/jimmunol.1301181","article-title":"Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo","volume":"191","author":"Zhang","year":"2013","journal-title":"J Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","article-title":"The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases","volume":"49","author":"Roncarolo","year":"2018","journal-title":"Immunity"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aah7152","article-title":"Eomesodermin promotes the development of type 1 regulatory T (TR1) cells","volume":"2","author":"Zhang","year":"2017","journal-title":"Sci Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(09)70074-9","article-title":"Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study","volume":"10","author":"Ciceri","year":"2009","journal-title":"Lancet Oncol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"317ra198","DOI":"10.1126\/scitranslmed.aac8265","article-title":"Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory","volume":"7","author":"Oliveira","year":"2015","journal-title":"Sci Transl Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1182\/blood-2014-01-551671","article-title":"Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"key":"B100","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1182\/blood-2015-02-628354","article-title":"Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation","volume":"125","author":"Zhou","year":"2015","journal-title":"Blood"},{"key":"B101","first-page":"130","article-title":"Donor T cells genetically modified with a novel suicide gene (inducible caspase 9, iC9) expand and persist over time after post-allograft infusion in patients given \u03b1\u03b2 T-cell and B-cell depleted HLA-haploidentical allogeneic stem cell transplantation (\u03b1\u03b2 haplo-HSCT) contributing to accelerate immune recovery","author":"Merli","year":"","journal-title":"Blood"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1158\/1078-0432.CCR-18-3069","article-title":"Phase I trial of inducible caspase 9 T cells in adult stem cell transplant demonstrates massive clonotypic proliferative potential and long-term persistence of transgenic T cells","volume":"25","author":"Zhang","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0505-5","article-title":"Effect of plasmapheresis on ATG (Thymoglobulin) clearance prior to adoptive T cell transfer","author":"Zhang","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"B104","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1182\/blood-2006-04-015230","article-title":"The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies","volume":"109","author":"Traversari","year":"2007","journal-title":"Blood"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","article-title":"HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-vs.-leukemia","volume":"276","author":"Bonini","year":"1997","journal-title":"Science"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1182\/blood-2005-08-3503","article-title":"Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation","volume":"107","author":"Berger","year":"2006","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1182\/blood-2004-11-4564","article-title":"An inducible caspase 9 safety switch for T-cell therapy","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1038\/cti.2014.11","article-title":"Adoptive T-cell therapy: adverse events and safety switches","volume":"3","author":"Tey","year":"2014","journal-title":"Clin Transl Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1182\/blood-2014-01-545020","article-title":"A highly compact epitope-based marker\/suicide gene for easier and safer T-cell therapy","volume":"124","author":"Philip","year":"2014","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","article-title":"A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"B111","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1182\/blood.V97.1.63","article-title":"Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft","volume":"97","author":"Tiberghien","year":"2001","journal-title":"Blood"},{"key":"B112","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.bbmt.2007.04.005","article-title":"Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation","volume":"13","author":"Tey","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1182\/blood-2012-01-405670","article-title":"T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation","volume":"120","author":"Vago","year":"2012","journal-title":"Blood"},{"key":"B114","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/mt.2015.217","article-title":"Clonal dynamics in vivo of virus integration sites of T cells expressing a safety switch","volume":"24","author":"Chang","year":"2016","journal-title":"Mol Ther"},{"key":"B115","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/bjh.14923","article-title":"Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation","volume":"179","author":"Chen","year":"2017","journal-title":"Br J Haematol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.bbmt.2018.07.008","article-title":"Reduced-intensity conditioning and dual T lymphocyte suppression with antithymocyte globulin and post-transplant cyclophosphamide as graft-vs.-host disease prophylaxis in haploidentical hematopoietic stem cell transplants for hematological malignancies","volume":"24","author":"Law","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B117","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S1083-8791(03)00127-7","article-title":"Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation","volume":"9","author":"Waller","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"B118","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1182\/blood-2002-09-2687","article-title":"Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications","volume":"102","author":"Morris","year":"2003","journal-title":"Blood"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1073\/pnas.0530192100","article-title":"Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia","volume":"100","author":"Marijt","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1182\/blood-2009-10-248997","article-title":"Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens","volume":"115","author":"Warren","year":"2010","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01854\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T21:40:41Z","timestamp":1575495641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01854\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":120,"alternative-id":["10.3389\/fimmu.2019.01854"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01854","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"article-number":"1854"}}